TECH Sell 13.05.2026 13:54
Pfizer Inc.: Murrey analysis
Four weeks ago, shares of Pfizer Inc., the largest US pharmaceutical company, began to decline, correcting within the medium-term upward trend: during this period, the price reversed from the 27.73 level (Murray level [7/8]), moved into the lower portion of the main Murray trading range, and is now testing the reversal level at 25.78 (Murray level [2/8]).
Indicators
Overall recommendation Buy
Overall recommendation Buy
Overall recommendation Active Buy
Overall recommendation Wait
Overall recommendation Wait
Overall recommendation Sell
Overall recommendation Sell